NETANYA, Israel, June 1, 2021 / PRNewswire / – Theranica, a digital prescribed therapeutics company developing advanced electroceuticals for migraine and other painful conditions, today announced that its FDA-approved laptop for the treatment of acute migraine NerivioÂ® was named the 2021 silver winner Award of Excellence in Medical Design (MDEA) in the Digital Health Products and Mobile Medical Applications category.
The MDEA, hosted by Informa Markets – Engineering, is an awards program dedicated to recognizing cutting-edge achievements in medical product design and celebrating the industry’s leading manufacturers who design breakthrough medical devices that change healthcare. to patients around the world.
âWe are honored to be recognized by the Medical Design Excellence Awards for the cutting edge technology behind Nerivio. The device’s unique design and ease of use make it an effective treatment option and we are committed to continuing to provide accessible pain relief to patients, âsaid Ronen Jashek, COO and co-founder of Theranica. “Nerivio is advancing the migraine treatment market by expanding options beyond medication – a long-awaited change in the field. Thanks to the jurors for recognizing this important first-line alternative treatment that helps patients manage this debilitating and pervasive disease. “
Nerivio, Theranica’s FDA-approved prescribed therapeutic wearable, is the first smartphone-controlled migraine treatment device that uses remote electrical neuromodulation (REN) to treat migraine pain. Worn on the upper arm for 45 minutes, the device stimulates the brain’s innate pain regulation mechanism to provide relief from migraine pain and symptoms. Treatment is personalized via the Nerivio app (available for iPhone and Android), which includes an interactive migraine diary that can be easily shared between patient and physician to improve migraine management.
Nerivio has also been named as one of the TIME’s best inventions of 2019. Patients interested in Nerivio should visit device website. Eligible for insurance coverage, Nerivio is available by prescription from any licensed healthcare provider and through the telemedicine platform UpScript. Nerivio is delivered directly to the patient’s home. Each Nerivio unit is valid for 12 treatments, after which it can be recycled and the prescription filled with a new device.
Theranica is a digital prescription therapeutics company dedicated to creating effective, safe, affordable, low-side effect electroceuticals for idiopathic pain. The company’s award-winning flagship product, NerivioÂ®, is the first FDA-approved, portable, smartphone-controlled device for the acute treatment of migraine and has provided more than 100,000 treatments. Theranica is expanding its proprietary technology to offer additional solutions for other pain conditions. Nerivio has received FDA clearance and CE mark for use in the acute treatment of episodic and chronic migraine in adult and adolescent patients.
About Informa Markets – Engineering:
Informa Markets Engineering Portfolio is the world’s leading B2B event producer, publisher and digital media company $ 3 trillion advanced and technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering marketplace and leverage our proprietary database of 1.3 million names to connect vendors with buyers and buy influencers. We produce over 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the world. The Engineering Portfolio is curated by Informa, the world’s leading exhibition organizer that brings a wide range of specialty markets to life, unlocks opportunities and helps them thrive 365 days a year. For more information, please visit www.informamarkets.com.